Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Altındağ
Clinical trial register · Turkey

Clinical Trials in Altındağ, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Altındağ

26 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Not yet open
Ankara Etlik City Hospital
Not applicable
100
Altındağ
2026-09-14
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Altındağ, Ankara, Antalya, Bakirkoy / Istanbul, Bornova, Izmir, Erdine, Istanbul, Izmir
2026-05-21
Recruiting
Comparison of the Analgesic Effects of TFPB in Renal Transplantation Surgery
NCT07542028Renal Transplantation, Peripheral Nerve Block, Pain Management
Ankara Etlik City Hospital
Not applicable
50
Altındağ
2026-04-27
Recruiting
Malnutrition Screening Study
NCT07256925Malnutrition, Calorie, Sarcopenia
Abbott Nutrition
Observational
7,500
Sarıçam, Altındağ, Çankaya, Yenimahalle, Kepez, Konyaalti, Muratpaşa, Nilufer
2026-01-12
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
75
Altındağ, Ankara, Center, Istanbul, Kocaeli
2025-11-26
Recruiting
Inflammatory Biomarkers as Predictors of PONV Following Pediatric Orchiopexy
NCT07148063Pediatric Anesthesia, Postoperative Nausea and Vomiting (PONV), Inflammatory Biomarkers
Diskapi Yildirim Beyazit Education and Research Hospital
Observational
170
Altındağ
2025-09-08
Recruiting
Diskapi Yildirim Beyazit Education and Research Hospital
Not applicable
65
Altındağ
2025-09-08
Recruiting
Ankara Etlik City Hospital
Not applicable
60
Altındağ
2025-08-18
Recruiting
Regeneron Pharmaceuticals
Phase 2
297
Seyhan, Altındağ, Istanbul, Bornova, Gaziantep, Adana, Ankara, Izmir
2025-05-28
By invitation
Ankara Training and Research Hospital
Observational
100
Altındağ
2025-05-15
Recruiting
AstraZeneca
Phase 3
1,220
Altındağ, Ankara, Erzurum, Istanbul, Izmir
2025-05-06
By invitation
Assessing the Relationship Between Frailty and Skeletal Muscle Thickness in Critically Ill Patients
NCT07310667Fraility, Nutrition Assessment, Ultrasound Evaluation, Critical Illness
Ankara Training and Research Hospital
Observational
80
Altındağ
2025-05-02
Recruiting
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
NCT06512883Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES)
AstraZeneca
Phase 3
14
Altındağ, Istanbul
2025-04-17
Recruiting
AstraZeneca
Phase 3
5,000
Adana, Adapazarı, Altındağ, Ankara, Antalya, Haliliye, Kahramanmaraş, Kayseri
2025-03-03
By invitation
Hacettepe University
Observational
32
Altındağ
2025-01-27
Recruiting
Comparison of the Postoperative Analgesic Efficacy of SPSIPB and ESPB in Anterior Cervical Discectomy
NCT06639022Anterior Cervical Discectomy, Peripheral Nerve Block, Pain Management
Ankara Etlik City Hospital
Not applicable
85
Altındağ
2024-10-15
Recruiting
AstraZeneca
Phase 3
620
Altındağ, Antalya, Istanbul, Izmir, Mezitli, Yakutiye
2024-08-12
Active, closed
Zydus Therapeutics Inc.
Phase 3
102
Altındağ, Ankara, Bursa, Cebeli, Melikgazi
2024-07-16
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
43
Altındağ, Ankara, Edirne, Erzurum, Istanbul
2024-04-02
Recruiting
Acrotech Biopharma Inc.
Phase 3
504
Altındağ, Çankaya, Yenimahalle, Şişli, Adana, Bornova
2023-10-04
Active, closed
Regeneron Pharmaceuticals
Phase 2/3
149
Adana, Altındağ, Istanbul, Bursa, Pendik, Bornova, Kocaeli, Konya
2023-06-30
Active, closed
Zenas BioPharma (USA), LLC
Phase 3
194
Altındağ, Pendik
2023-01-09
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
154
Altındağ, Bornova, Istanbul
2022-07-13
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Alanya, Altındağ, Ankara, Antalya, Atakum, Bahçelievler, Bornova, Çankaya
2020-12-02
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/alt-nda

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Altındağ.

How many clinical trials are recruiting in Altındağ?

16 of the 26 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 6 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Altındağ), 26 studies
PhaseStudiesRecruitingShare
Phase 310638.5%
Not applicable5419.2%
Observational5219.2%
Phase 23211.5%
Phase 2/33211.5%

Most active sponsors

Lead sponsors with the most studies (Altındağ)
Lead sponsorStudiesRecruiting
Ankara Etlik City Hospital43
AstraZeneca44
Alexion Pharmaceuticals, Inc.21
Ankara Training and Research Hospital20
Diskapi Yildirim Beyazit Education and Research Hospital22
Regeneron Pharmaceuticals21
Abbott Nutrition11
Acrotech Biopharma Inc.11
Bristol-Myers Squibb10
CorMedix Therapeutics11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.